Get started
Author

Silvia Scriffignano

Observed names: S Scriffignano, S. Scriffignano, SILVIA SCRIFFIGNANO, Scriffignano, Silvia
Observed institutions: University of Rome Tor Vergata, University of Molise, University of Campania "Luigi Vanvitelli", Universitair Ziekenhuis Leuven, Fondazione Istituto G. Giglio di Cefalù, KU Leuven
ORCID: 0000-0001-5774-9643
Observed ORCID: 0000-0001-5774-9643
OpenAlex ID: A5012801105
Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
2022 · Fabio Massimo Perrotta, Silvia Scriffignano, et al. · Rheumatology and Therapy · 68
PDF
Psoriatic Arthritis, Psoriatic Disease, or Psoriatic Syndrome?
2019 · ENNIO LUBRANO, SILVIA SCRIFFIGNANO, et al. · The Journal of Rheumatology · 57
PDF
Psoriatic Arthritis in Males and Females: Differences and Similarities
2023 · Ennio Lubrano, Silvia Scriffignano, et al. · Rheumatology and Therapy · 44
PDF
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
2023 · Ennio Lubrano, Silvia Scriffignano, et al. · Rheumatology and Therapy · 40
PDF
Role of comorbidities in spondyloarthritis including psoriatic arthritis
2018 · Silvia Scriffignano, Fabio Massimo Perrotta, et al. · Clinical Rheumatology · 40
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices
2020 · Ennio Lubrano, Silvia Scriffignano, et al. · RMD Open · 39
PDF
Residual Disease Activity and Associated Factors in Psoriatic Arthritis
2019 · Ennio Lubrano, Silvia Scriffignano, et al. · The Journal of Rheumatology · 38
PDF
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study
2020 · Ennio Lubrano, Silvia Scriffignano, et al. · Rheumatology and Therapy · 37
PDF
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review
2021 · Fabio Massimo Perrotta, Silvia Scriffignano, et al. · Rheumatology and Therapy · 35
PDF
Multimorbidity and comorbidity in psoriatic arthritis – a perspective
2020 · Ennio Lubrano, Silvia Scriffignano, et al. · Expert Review of Clinical Immunology · 35
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
2019 · Ennio Lubrano, Fabio Massimo Perrotta, et al. · Rheumatology and Therapy · 27
PDF
Triple jump for the optimal management of psoriatic arthritis: diet, sleep and exercise – a review
2023 · Ennio Lubrano, Silvia Scriffignano, et al. · RMD Open · 26
PDF
Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study
2018 · Fabio Massimo Perrotta, Fulvia Ceccarelli, et al. · Journal of Immunology Research · 22
PDF
A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis
2023 · Dennis McGonagle, Roberta Ramonda, et al. · Autoimmunity Reviews · 21
Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort
2022 · Daniele Mauro, Antonio Ciancio, et al. · Frontiers in Immunology · 21
PDF
Therapeutic Targets for Ankylosing Spondylitis – Recent Insights and Future Prospects
2022 · Fabio Massimo Perrotta, Silvia Scriffignano, et al. · Open Access Rheumatology Research and Reviews · 20
PDF
TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis
2019 · Ennio Lubrano, Silvia Scriffignano, et al. · Expert Review of Clinical Immunology · 19
Difficult-to-Treat Concept in Psoriatic Arthritis: Analysis of 2 Potential Definitions in a Large Group of Patients. A Cross-Sectional Study
2024 · Fabio Massimo Perrotta, Stefano Gentileschi, et al. · The Journal of Rheumatology · 15
PDF
The “Climb” Towards Minimal Disease Activity in Psoriatic Arthritis
2021 · Ennio Lubrano, Silvia Scriffignano, et al. · Rheumatology and Therapy · 15
PDF
Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations
2022 · Silvia Scriffignano, Rik Lories, et al. · Clinical and Experimental Rheumatology · 14
PDF
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study
2020 · F.M. Perrotta, A. Delle Sedie, et al. · Reumatismo · 14
PDF
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings
2019 · Fabio Massimo Perrotta, Silvia Scriffignano, et al. · Rheumatology and Therapy · 13
PDF
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study
2018 · Fabio Massimo Perrotta, Antonia De Socio, et al. · Clinical Rheumatology · 11
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective
2022 · Ennio Lubrano, Silvia Scriffignano, et al. · Rheumatology and Therapy · 10
PDF
Assessment of Widespread and Extraarticular Pain in Psoriatic Arthritis: A Case-control Study
2021 · Ennio Lubrano, Silvia Scriffignano, et al. · The Journal of Rheumatology · 10
PDF
Works count: 73
Citation count: 801
H-index: 17
I10-index: 26
Year
Topic
Type